Paper Details

  1. Home
  2. Paper Details

Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study.

Author: DuHong, HuangDe-sheng, LiangGuang-ming, TongJian-hua, WangMan, ZhuGang

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Depression is the main cause of disability for people with bipolar disorder. While treatments for depression in bipolar disorder are often based on experience, not strong evidence, this study investigates the effectiveness of olanzapine, an antipsychotic medication, used alone to treat depression in people with bipolar I disorder.
Paper Details　
Original Abstract of the Article :
Depression symptoms are now recognized to be the predominant cause of disability for bipolar disorder (BD) patients. The treatment strategies for the depressed phase of BD remain more anecdotal than data-based. Olanzapine has been investigated as an alternative to antidepressants and a mood stabiliz...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00213-014-3453-1

データ提供：米国国立医学図書館（NLM）

Olanzapine: A Potential Oasis for Bipolar I Depression?

The realm of [bipolar disorder (BD)] is vast and complex, much like the endless dunes of a desert. Understanding the ebb and flow of mood swings is critical for effective treatment. This research, like a seasoned explorer, delves into the efficacy of [olanzapine monotherapy] for [bipolar I depression]. Using a randomized, double-blind, placebo-controlled study, the researchers examined the effects of olanzapine on individuals experiencing a depressive episode. Their findings provide valuable insights into the potential of this medication in managing this challenging aspect of BD.

Navigating the Depressive Phase of Bipolar Disorder

The study found that olanzapine may be a beneficial option for treating bipolar I depression. This discovery is crucial as it offers a beacon of hope for individuals struggling with the depressive phase of this disorder. The results highlight the potential of olanzapine as a therapeutic alternative to traditional antidepressants and mood stabilizers, offering a new avenue for managing this debilitating condition.

A New Approach to Bipolar I Depression

Olanzapine's potential to help stabilize mood fluctuations in individuals with bipolar I depression suggests a promising approach for managing this disorder. It's like finding a hidden spring in the heart of a desert, offering a refreshing change from the usual strategies. By understanding the specific effects of olanzapine, healthcare professionals can personalize treatment plans and provide more targeted care for their patients. However, like any oasis, it's essential to approach this new potential solution with careful consideration and a comprehensive understanding of its nuances.

Dr.Camel's Conclusion

This research, like a shimmering mirage, reveals the potential of olanzapine for treating bipolar I depression. It underscores the importance of exploring novel therapeutic approaches in managing this complex disorder. With its promising findings, this study offers a ray of hope for individuals battling the emotional rollercoaster of bipolar I depression, offering a potential pathway to a more stable and fulfilling life.

Date :
  1. Date Completed 2015-02-09
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24481570

DOI: Digital Object Identifier

10.1007/s00213-014-3453-1

Related Literature

Article Analysis
・Effective treatment of bipolar disorder
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.